<DOC>
	<DOCNO>NCT00437398</DOCNO>
	<brief_summary>The complex program insulin replacement type 1 diabetes current clinical standard care difficult implement long periods time , associate increase risk severe hypoglycemia implement less 50 % population patient . Outcomes transplantation isolated human islet substantially improve perform 40 institution around world . We propose clinical phase 1/phase 2 study islet transplantation alone evaluate safety efficacy five patient type 1 diabetes . Islet isolation decease donor pancreas perform Mayo Rochester Islet Isolation facility islet infuse Interventional Radiology portal venous system . Following islet infusion , patient hospitalize 48 hour General Clinical Research Center ( GCRC ) Rochester Methodist Hospital . Multiple safety efficacy outcomes follow multiple occasion first year periodically thereafter .</brief_summary>
	<brief_title>Islet Transplantation Type 1 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Duration diabetes : 5 year Type 1 diabetes Cpeptide &lt; 200 pmol/L simultaneous plasma glucose 60 250 mg/dl Complex insulin program supervise endocrinologist least 6 month Hypoglycemic unawareness diagnose use Clarke Awareness Questionnaire Body weight &lt; 70 kg Body Mass Index &lt; 30 kg/m^2 Insulin requirement &lt; 40 units/day multiple daily injection &lt; 30 unit /day external insulin pump &lt; 0.6 unit/kg/day HbA1c &lt; 7.0 % ( Normal &lt; 6 % ) No overt cardiovascular disease No laser treatment retinopathy Retinopathy diagnose ophthalmologist stable require evaluation least one year Women child bear age negative pregnancy test screening time trial initiation Women enrol trial willing practice birth control immunosuppression No psychologic issue would interfere adherence safe clinical practice Blood type ( ABO ) compatibility No evidence chronic liver disease ( aspartate aminotransferase ( AST ) &lt; 2.5 time normal , alanine aminotransferase ( ALT ) &lt; 2.5 time normal , international normalize ratio ( INR ) &lt; 1.4 , No evidence fatty liver abdominal ultrasound . Ongoing infection Ongoing alcohol drug abuse Clinical portal hypertension Gall stone Liver hemangioma ultrasound interfere islet infusion Lack updated immunization Unstable cardiovascular status define : 1 . Myocardial infarction/acute coronary syndrome last year 2 . Significant coronary atherosclerosis angiography 3 . Active ischemia evaluation Pretrial lowdensity lipoprotein ( LDL ) cholesterol &gt; 100 triglyceride &gt; 200 mg/dl without lipid lower therapy Active peptic ulcer disease Previous organ transplantation except islet transplantation Negative serology EpsteinBarr Virus ( EBV ) ongoing acute EBV infection Previous malignancy unless 1 . 5 year ago 2. basal cell cancer 3. squamous cell cancer Requiring steroid therapy reason Positive Purified Protein Derivative ( PPD Tuberculosis Skin Test ) Serological evidence HIV , Hepatitis C Hepatitis B Chronic anemia Single Antigen B ( SAB ) normalize value &gt; 1500 Renal disease 1 . Iothalamate clearance &lt; 70 cc/min 2 . 24 hour urine protein &gt; 500 mg/24 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>hypoglycemic unawareness</keyword>
</DOC>